(Aryloxy)[p-(aryloxy)phenyl]- and (aryloxy)[p-(arylthio)phenyl]acetic acids and esters as hypolipidemic agents

Authors:
  • RTRonald I. Trust
    Ronald I. Trust
  • FMFrancis J. McEvoy
    Francis J. McEvoy
  • JAJ. Donald Albright
    J. Donald Albright

Abstract
A series of (arylox)[p-(aryloxy)phenyl]- and (aryloxy)[p-(arylthio)phenyl]acetic acids and esters of general structure were prepared and tested for lipid-lowering activity in normal rats. At a dose of 0.1% of the diet (.apprx. 100 mg/kg), approximately half of the compounds reduced serum sterols in the range of 20-30% and lowered serum triglycerides by 40-60%. Over 35 analogs lowered serum sterols by 15-25% when fed at 0.03% of diet, and 15 of these maintained their activity at 0.01% of the diet (10 mg/kg). Synthetic methodology and structure-activity relationships are discussed.